VEGF inhibitors aggravate ALS, possibly by reducing neural perfusion

Koen Poesen; Koen Nelissen; Diether Lambrechts; Erik Storkebaum; Lieve Moons; Désiré Collen; Peter Carmeliet

Related publications

Letter2006

VEGF inhibitors make blood

Christian Fischer, Peter Carmeliet, Edward M. Conway

Article2004

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS

Erik Storkebaum, Diether Lambrechts, Mieke Dewerchin, Paz Moreno-Murciano, Saskia Appelmans, Hideyasu Oh, Philip Van Damme, Bart P. F. Rutten, W.Y. Man, Maria De Mol, Sabine Wyns, David Manka, Kristel Vermeulen, Ludo Van Den Bosch, Nico Mertens, Christoph Schmitz, Wim Robberecht, Edward M. Conway, D Collen, Lieve Moons, Peter Carmeliet

Article2004

VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?

Diether Lambrechts, Erik Storkebaum, Peter Carmeliet

Article2005

A novel role for VEGF-B in motorneuron degeneration in ALS

Diether Lambrechts, Peggy Lafuste, Désiré Collen, Mieke Dewerchin, Lieve Moons, Peter Carmeliet

Chapter in a book2006

VEGF, an Angiogenic Factor with Neurotrophic Activity, Useful for Treatment of ALS?

Diether Lambrechts, Peter Carmeliet